Evidence map›Paper›PMID 35450053›Full record

ArticleFrontiers in pharmacology2022

Impact of Three Safety Interventions Targeting Off-Label Use of Immediate-Release Fentanyl on Prescription Trends: Interrupted Time Series Analysis.

Aníbal García-Sempere, Isabel Hurtado, Salvador Peiró, Francisco Sánchez-Sáez, Clara Liliana Rodríguez-Bernal, Magda Puig-Ferrer, Manuel Escolano, Gabriel Sanfélix-Gimeno

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Aníbal García-SempereFoundation for the Promotion of Health and Biomedical Research of Valencia Region, FISABIO, Valencia, Spain.
Isabel HurtadoFoundation for the Promotion of Health and Biomedical Research of Valencia Region, FISABIO, Valencia, Spain.
Salvador PeiróFoundation for the Promotion of Health and Biomedical Research of Valencia Region, FISABIO, Valencia, Spain.
Francisco Sánchez-SáezFoundation for the Promotion of Health and Biomedical Research of Valencia Region, FISABIO, Valencia, Spain.
Clara Liliana Rodríguez-BernalFoundation for the Promotion of Health and Biomedical Research of Valencia Region, FISABIO, Valencia, Spain.
Magda Puig-FerrerGeneral Directorate for Pharmacy, Valencia Health System, Valencia, Spain.
Manuel EscolanoGeneral Directorate for Pharmacy, Valencia Health System, Valencia, Spain.
Gabriel Sanfélix-GimenoFoundation for the Promotion of Health and Biomedical Research of Valencia Region, FISABIO, Valencia, Spain.
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESGeneralitat Valenciana · ESSpanish Clinical Research Network · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

appropriateness of prescriptionfentanylinterrupted time seriespharmacoepidemiologypolicy interventions

Identifiers

PMID35450053
PMCPMC9016332
OpenAlexW4226148168

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.